In the United States, colored contacts are prescription medical devices that require a professional fitting, even when they have no vision-correcting power. If you look up a lens in FDA records, you may find a downloadable 510(k) Summary, a database entry marked Statement, or an older record with limited electronic documents. Those results do not represent different levels of clearance. They reflect two disclosure routes a 510(k) submitter could choose under 21 CFR 807.92 and 21 CFR 807.93.
The direct answer is simple: a 510(k) Summary places a concise account of the substantial-equivalence basis in the public FDA record, while a 510(k) Statement is a signed commitment by the submitter to provide releasable safety and effectiveness information after a written request. Neither document replaces your prescription, confirms that a particular seller is legitimate, or tells an eye doctor whether the lens fits your eyes.
Why two cleared contact lens records can look so different
FDA’s 510(k) system is a premarket review pathway for many medical devices. A submitter identifies a legally marketed device and provides information supporting a finding that the new device is substantially equivalent. For contact lenses, the record may include the device name, applicant, product code, decision date, regulation number, review panel, and a field labeled Summary or Statement.
That last field is about public disclosure, not about whether FDA performed a scientific review. FDA’s 510(k) content guidance says every submission must include either a Summary or a Statement before scientific review can begin. The applicant may change that choice before FDA reaches its substantial-equivalence determination, but not after the determination.
This distinction matters when comparing colored contact records. One entry may open a short PDF that describes materials, indications, technological characteristics, performance testing, and conclusions. Another may show only STATEMENT and the applicant’s contact information. The second device did not necessarily receive less review. Its submitter chose the request-based disclosure route instead of the public summary route.
This article is about those document types. If you need search steps, filters, and number matching, use our separate guide on finding a colored contact’s FDA 510(k) record. If you are trying to understand the comparison device named in a submission, read our explanation of what a 510(k) predicate means. A predicate and a Summary or Statement are related concepts, but they are not interchangeable.
510(k) Summary under 21 CFR 807.92
A 510(k) Summary is a compact public account of the information supporting the submitter’s substantial-equivalence claim. Under 21 CFR 807.92, it must contain enough detail for a reader to understand the basis of the determination. It is not the complete application, and it is not simply a marketing sheet.
The required content includes the submitter’s identity and contact information; the device’s trade, common, and classification names; identification of the legally marketed comparison device; a description of how the new device functions; significant design, material, physical, and performance characteristics; and the intended use. When indications differ from those of the comparison device, the Summary must explain why those differences do not alter the device’s safety and effectiveness when used as labeled.
The Summary also describes technological characteristics relative to the comparison device. If performance data contribute to the substantial-equivalence determination, the document provides a brief discussion of relevant nonclinical testing and, when applicable, clinical testing, followed by the conclusions drawn from those tests. It summarizes results rather than publishing every protocol page, raw measurement, communication, and attachment in the submission.
For a colored contact lens, a Summary may help a reader identify material, wear schedule, intended use, optical properties, sterilization approach, packaging claims, or testing categories. The exact details vary by device and record. Read the language actually present rather than assuming every Summary contains the same tables. For terminology that appears elsewhere in a record, our guides explain the difference between daily wear and daily disposable and what the Rx Only symbol does and does not establish.
FDA states that a qualifying Summary is placed on the internet after the substantial-equivalence decision. That makes the Summary the easier route for a shopper or clinician who wants a quick public explanation. Still, the PDF should be treated as a regulatory summary written for a specific clearance decision. It is not an endorsement, a ranking, a promise of comfort, or evidence that an online listing matches the cleared device.
510(k) Statement under 21 CFR 807.93
A 510(k) Statement is not a shorter version of the Summary. It is a signed certification using the language required by 21 CFR 807.93. The certifier commits to make the safety and effectiveness information included in the premarket notification available to any person within 30 days after receiving a written request, once FDA has found the device substantially equivalent.
The releasable copy is not necessarily identical to every page FDA received. Patient identifiers are excluded, as are trade secrets and confidential commercial information under the applicable disclosure rules. The regulation also requires written requests to go to the certifier whose name FDA publishes with the cleared submission. FDA’s guidance says the applicant may not charge a requester for compiling and distributing the material.
In practical terms, the FDA database may not give you an immediate safety-and-effectiveness PDF for a Statement record. Instead, it tells you that the releasable information may be obtained from the applicant. That difference can be inconvenient, especially when an applicant has changed names, moved, merged, or no longer maintains the contact listed in an old record. It does not convert a Statement into evidence of a weaker decision.
A Statement also should not be confused with FDA’s decision letter, the database’s clearance metadata, labeling, a patient information booklet, or a package insert. Those materials serve different functions. A request for Statement material should identify the exact K number, device name, applicant, and decision date so the recipient can locate the correct submission.
Document comparison: what each route provides
| Question | 510(k) Summary | 510(k) Statement |
|---|---|---|
| Governing provision | 21 CFR 807.92 | 21 CFR 807.93 |
| What it is | A concise account of the basis for substantial equivalence | A signed commitment to release eligible submission information after a written request |
| How a reader usually gets information | FDA generally posts the Summary with the public clearance record | The requester writes to the applicant or certifier identified for the record |
| Typical scope | Device identity, intended use, comparison device, technology, testing discussion, and conclusions | A duplicate of releasable submission information, subject to required exclusions |
| Timing | Public posting follows the substantial-equivalence decision | The certification promises a response within 30 days of a written request |
| Key limits | It is a summary, not the complete file or raw data set | Patient identifiers, trade secrets, and confidential commercial information are excluded |
| What it does not prove | Current prescription status, seller legitimacy, individual fit, or product authenticity | Current prescription status, seller legitimacy, individual fit, or product authenticity |
What the public FDA record can and cannot tell you
The FDA releasable 510(k) database is an index and document access point. It can help you connect a K number with a device name, applicant, product code, decision date, and Summary or Statement designation. It is useful for establishing that FDA recorded a substantial-equivalence decision for the identified device.
The public record cannot, by itself, authenticate a box in your hand. A marketplace seller may reuse a legitimate K number, list a similar name, omit the actual manufacturer, or combine images from different products. Check the applicant, device name, product code, labeling details, and package information together. A clearance belonging to one device or company does not automatically cover every lens sold under a similar description.
Clearance also is not the same as approval. A 510(k) result is a substantial-equivalence determination for the device and intended use reviewed through that pathway. Avoid phrases such as “FDA approved” unless the record actually concerns an approval pathway. Likewise, a foreign conformity mark does not replace US authorization, as discussed in our guide to CE marks and US colored contact sales.
The record does not determine whether the lens is right for you. Base curve, diameter, power, material, surface behavior, movement, centration, and your ocular health all affect a fitting. National Eye Institute guidance on decorative lenses explains that decorative contacts remain regulated medical devices and should be obtained through proper eye care. A K number is never a substitute for that clinical process.
Why older records may have fewer online documents
Historical 510(k) entries can be harder to interpret than recent records. The database spans decades during which electronic filing, scanning, web publication, company names, and document conventions changed. An older entry may provide basic metadata and a Summary or Statement marker without the same searchable PDF package you would expect from a newer file.
Do not treat a missing download button as proof that a device was never cleared. First confirm the K number and database entry. Check whether the record says SUMMARY or STATEMENT. For a Statement, request-based access is the expected route. For a Summary with no accessible PDF, the document may require additional record research or a request to FDA. An incomplete web presentation and an absent regulatory decision are different findings.
Historical names create another trap. The applicant shown at clearance may not be the current distributor, brand owner, or customer-service contact. Corporate changes do not rewrite every old database entry. Search using the K number first, then compare names and addresses across the record, labeling, and packaging. Our separate article on FDA warning letters and inspection classifications can help when you are reviewing later compliance information, but those records answer a different question from a 510(k) disclosure document.
There are also lawful disclosure limits. A Summary intentionally condenses the basis for the decision. Statement material excludes protected categories. FDA’s public database does not promise every internal review note, proprietary manufacturing detail, patient identifier, or piece of raw data. A gap may reflect the selected disclosure route, a legal exclusion, an older archive, or a technical access issue. It should prompt a narrower search, not an invented conclusion.
A careful way to read a contact lens entry
- Match the identifier. Start with the exact K number, not only a brand or shade name. One digit changes the record.
- Confirm the device and applicant. Compare the device name, classification name, applicant, decision date, and product code with the claims being made.
- Read the Summary or Statement field literally. SUMMARY points to a public summary route. STATEMENT points to applicant-provided information after a written request.
- Keep documents in their lanes. Do not use a Statement as though it were a predicate, or a Summary as though it were a current prescription or sales license.
- Record what is missing. Note whether the PDF, labeling, contact information, or older scan is unavailable. State the limitation instead of filling it with assumptions.
- Check later safety and compliance records separately. Recalls, import alerts, warning letters, and adverse-event reports are separate systems. Our FDA import alert guide explains one of those tools.
- Return to the prescription and fitting. Even a well-documented clearance record does not establish safe wear for an individual patient.
Common interpretation mistakes
One common error is assuming that a Summary is more favorable because it is immediately visible. The two options concern disclosure mechanics. FDA still must reach a substantial-equivalence decision before either route has the post-clearance effect described here.
Another error is reading the comparison device as a product recommendation. A predicate is part of the regulatory comparison supporting substantial equivalence. It does not mean the new lens is identical in every specification, nor does it tell you which product will fit an individual eye. Keep predicate analysis in the separate predicate article rather than turning this document question into a product comparison.
A third error is treating a sparse historical page as proof of fraud. Sparse data can justify caution and more research, but it is not a finding by itself. Conversely, a polished PDF and valid K number do not validate a seller’s inventory. If a listing or package seems mismatched, preserve the URL, photographs, lot information, and correspondence. For a suspected device problem, see how to report a colored contact issue through FDA MedWatch.
Finally, avoid turning regulatory research into self-fitting. The American Optometric Association’s contact lens safety guidance explains that contacts are medical devices that must be fitted and prescribed after an eye health and vision exam. Document research can support informed questions. It cannot measure lens movement, assess the cornea, or issue a prescription.
Official sources
- FDA: Content of a 510(k)
- FDA: Search the Releasable 510(k) Database
- National Eye Institute: Decorative Contact Lenses
- American Optometric Association: Contact Lens Safety and Prescription Verification
Frequently asked questions
Does a 510(k) Statement mean FDA did not review the device?
No. The Statement is a disclosure choice within the 510(k) submission. FDA still reviews the submission and must find the device substantially equivalent before the post-clearance disclosure commitment applies.
Is a 510(k) Summary the complete FDA submission?
No. It summarizes the basis for substantial equivalence, including required device, comparison, technology, testing, and conclusion information. It does not reproduce every page, raw data set, or protected detail.
How do I obtain information for a record marked STATEMENT?
Send a written request to the certifier or applicant identified for the record. Include the exact K number, device name, applicant, and decision date, and keep a copy of the request.
Can the applicant remove confidential information from Statement material?
Yes. The releasable copy excludes patient identifiers, trade secrets, and confidential commercial information. The disclosure commitment does not erase those legal protections.
Why does an older 510(k) record have no downloadable PDF?
Older records may have limited electronic files, scans, or indexing. The entry may also use the Statement route. Confirm the K number and designation before deciding what additional request is appropriate.
Is the predicate device the same thing as the 510(k) Summary?
No. The predicate is the legally marketed comparison device used in substantial-equivalence analysis. The Summary is a disclosure document that explains the basis for the determination and identifies the comparison device.
Does a public 510(k) record prove an online colored contact is authentic?
No. A valid record can be copied or misapplied in a listing. Compare the applicant, device name, product code, labeling, packaging, and seller information, and do not rely on the K number alone.
Can I use a 510(k) document instead of getting a contact lens prescription?
No. The document describes a regulatory clearance record. It does not assess your eyes, authorize a seller to substitute lenses, or replace a current prescription and professional contact lens fitting.